• 1
    Paterson, D. J., Jefferies, W. A., Green, J. R., Brandon, M. R., Corthesy, P., Puklavec, M. and Williams, A. F., Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol. Immunol. 1987. 24: 12811290.
  • 2
    Mallett, S., Fossum, S. and Barclay, A. N., Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes: a molecule related to nerve growth factor receptor. EMBO J. 1990. 9: 10631069.
  • 3
    Calderhead, D. M., Buhlmann, J. E., van den Eertwegh, A. J., Claassen, E., Noelle, R. J. and Fell, H. P., Cloning of mouse OX40: a T cell activation marker that may mediate T-B cell interactions. J.Immunol. 1993. 151: 52615271.
  • 4
    Latza, U., Durkop, H., Schnittger, S., Ringeling, J., Eitelbach, F., Hummel, M., Fonatsch, C. and Stein, H., The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol. 1994. 24: 677682.
  • 5
    Al-Shamkhani, A., Birkeland, M. L., Puklavec, M., Brown, M. H., James, W. and Barclay, A. N., OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur. J. Immunol. 1996. 26: 16951699.
  • 6
    Baum, P. R., Gayle 3rd, R. B., Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., Seldin, M. F., Baker, E., Sutherland, G. R. and Clifford, K. N., Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 1994. 13: 39923998.
  • 7
    Godfrey, W. R., Fagnoni, F. F., Harara, M. A., Buck, D. and Engleman, E. G., Identification of a human OX40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J. Exp. Med. 1994. 180: 757762.
  • 8
    Weinberg, A. D., OX40: targeted immunotherapy — implications for tempering autoimmunity and enhancing vaccines. Trends Immunol. 2002. 23: 102109.
  • 9
    Gramaglia, I., Jember, A., Pippig, S. D., Weinberg, A. D., Killeen, N. and Croft, M., The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 2000. 165: 30433050.
  • 10
    Bansal-Pakala, P., Jember, A. G. H. and Croft, M., Signaling through OX40 (CD134) breaks peripheral T cell tolerance. Nat. Med. 2001. 7: 907912.
  • 11
    Arestides, R. S. S., He, H., Westlake, R. M., Chen, A. I., Sharpe, A. H., Perkins, D. L. and Finn, P. W., Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur. J. Immunol. 2002. 32: 28742880.
  • 12
    Roger, P. R., Song, J., Gramaglia, I., Killeen, N. and Croft, M., OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 2001. 15: 445455.
  • 13
    Weinberg, A. D., Rivera, M. -M., Prell, R., Morris, A., Ramstad, T., Vetto, J. T., Urba, W. J., Alvord, G., Bunce, C. and Shields, J., Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J. Immunol. 2000. 164: 21602169.
  • 14
    Weinberg, A. D., Sullivan, T. J., Lemon, M., Wallin, J. J., Bourdette, D. N., Harmon, R. C., Fulton, R. J., Offner, H. and Vandenbark, A. A., Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat. Med. 2000. 2: 183189.
  • 15
    Simon, H.-U., Neutrophil apoptosis pathways and their modifications in inflammation. Immunol. Rev. 2003. 193: 101110.
  • 16
    Dibbert, B., Weber, M., Nikolaizik, W. H., Vogt, P., Schöni,M. H., Blaser, K. and Simon, H.-U., Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc. Natl. Acad. Sci. USA 1999. 96: 1333013335.
  • 17
    Baumann, R., Casaulta, C., Simon, D., Conus, S., Yousefi, S. and Simon, H.-U., Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J. 2003. 17: 22212230.
  • 18
    Altznauer, F., Conus, S., Cavalli, A., Folkers, G. and Simon, H.-U., Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J. Biol. Chem. 2004. 279: 59475957.
  • 19
    Martin, S. J., Reutelingsperger, C. P. M., McGahon, A. J., Rader, J. A., van Schie, R. C. A. A., LaFace, D. M. and Green, D. R., Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 1995. 182: 15451556.
  • 20
    Daigle, I. and Simon, H.-U., Critical role for caspases 3 and 8 in neutrophil but not eosinophil apoptosis. Int. Arch. Allergy Immunol. 2001. 26: 147156.
  • 21
    Krammer, P. H., CD95s deadly mission in the immune system. Nature 2000. 407: 789795.
  • 22
    Luo, X., Budihardjo, I., Zou, H., Slaughter, C. and Wang, X., Bid, a Bcl-2 interacting protein, mediates cytochrome c release in response to activation of cell surface death receptors. Cell 1998. 94:481490.
  • 23
    Liu, H., Zhu, H., Xu, C., and Yuan, J., Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998. 94: 491501.
  • 24
    Moulding, D. A., Quayle, J. A., Hart, C. A. and Edwards, S. W., Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood 1998. 92: 24952502.
  • 25
    Iway, K., Miyawaki, T., Takizawa, T., Konno, A., Ohta, K., Yachie, A., Seki, H. and Taniguchi, N., Differential expression of bcl-2 and susceptibility toanti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994. 84: 12011208.
  • 26
    Yoshioka, T., Nakajima, A., Akiba, H., Ishiwata, T., Asano, G., Yoshino, S., Yagita, H. and Okumura, K., Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur. J. Immunol. 2000. 30: 28152823.
  • 27
    Stuber, E., Buschenfeld, A., Luttges, J., von Freier, A., Arendt, T. and Folsch, U. R., The expression of OX40 in immunologically mediated diseases of the gastrointestinal tract (celiac disease, Crohn's disease, ulcerative colitis). Eur. J. Clin. Invest. 2000. 30: 594599.
  • 28
    Vetto, J. T., Lum, S., Morris, A., Sicotte, M., Davis, J., Lemon, M. and Weinberg, A., Presence of the T cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Am. J. Surg. 1997. 174: 258265.
  • 29
    Humphreys, I. R., Walzl, G., Edwards, L., Rae, A., Hill, S. and Hussell, T., A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J. Exp. Med. 2003. 198: 12371242.
  • 30
    Maianski, N. A., Mul, F. P. J., van Buul, J. D., Roos, D. and Kuijpers, T. W., Granulocyte colony-stimulating factors inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood 2002. 99: 672679.
  • 31
    Fecho, K. and Cohen, P. L., Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils. J. Leukoc. Biol. 1998. 64: 373383.
  • 32
    Kunitomi, A., Toshiyuki, H., Imura, A. and Uchiyama, T., Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system. J. Leukoc. Biol. 2000. 67: 111118.
  • 33
    Imura, A., Hori, T., Imada, K., Ishikawa, T., Tanaka, Y., Maeda, M., Imamura, S. and Uchiyama, T., The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 1996. 183: 21852195.
  • 34
    Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C. and Delespesse, G., Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 1997. 159: 38383848.
  • 35
    Heinisch, I. V. W. M., Daigle, I., Knöpfli, B. and Simon, H.-U., CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils. Eur. J. Immunol. 2000. 30: 34413446.
  • 36
    Daigle, I., Yousefi, S., Colonna, M., Green, D. R. and Simon, H.-U., Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signalling in neutrophils. Nat. Med. 2002. 8: 6167.
  • 37
    Altznauer, F., Martinelli, S., Yousefi, S., Thürig, C., Schmid, I., Conway, E. M., Schöni, M. H., Vogt, P., Mueller, C., Fey, M. F., Zangemeister-Wittke, U. and Simon, H.-U., Inflammation-associated cell-cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 2004. 199: 13431354.